Principal investing

Five Prime Capital Partners is a medical technology and life sciences focused venture capital and private equity investor. We identify proprietary investment opportunities in sectors we follow closely as advisors. Occasionally, we consider investing alongside a client. We seek to partner with strong, experienced management teams, providing financial resources and operating, strategic, and transactional expertise. We benefit from relationships with senior industry executives who can serve at the board level or as a temporary member of a management group. We are headquartered in New York, with satellite offices in California, Latin America and Europe.

BioView Ltd. is an Israel-based developer and manufacturer of an innovative and highly regarded cell diagnostic system for use in cytology, cytogenetics, hematology, and pathology. The company is focused on the cancer monitoring and cytogenetics markets. Current solutions include tests for leukemia, multiple myeloma, bladder cancer, rare cell detection, and breast cancer. BioView is the technical leader in these markets providing one of only a few FDA-approved systems for analysis utilizing fluorescent in-situ hybridization. This technology is unique in that it allows the pathologist and scientist the ability to simultaneously analyze the same cell for both morphology and genetic content at significantly higher throughputs than are achievable with alternative technologies.
www.bioview.co.il

Mendel Biotechnology, Inc. is a pioneer in the application of functional genomics to the study of plants. The company focuses its research efforts on identifying those transcription factors responsible for regulating traits that improve yield and nutritional value in commercially important crops, such as corn, soybeans, wheat, and rice. Technologies developed by Mendel are in various stages of commercialization. Strategic partners include Monsanto, BP and Bayer CropScience. Monsanto is a significant, early investor in the company.
www.mendelbio.com